Reparixin, an inhibitor of CXCR2 function, attenuates inflammatory responses and promotes recovery of function after traumatic lesion to the spinal cord

Journal of Pharmacology and Experimental Therapeutics

Volumn 322, Issue 3, 2007, Pages 973-981

  Gorio, Alfredo ^a,b,d   Madaschi, Laura ^a   Zadra, Giorgia ^a   Marfia, Giovanni ^a   Cavalieri, Barbara ^c   Bertini, Riccardo ^c   Di Giulio, Anna Maria ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^c Chemistry Section   (Italy)

^d Pharmacological Laboratories   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR2; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; METHYLPREDNISOLONE SODIUM SUCCINATE; PROTEIN; PROTEIN INHIBITOR; PROTEIN NG2; REPARIXIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD LEVEL; CELL MIGRATION; CELL PROLIFERATION; CONTINUOUS INFUSION; CONTROLLED STUDY; CONVALESCENCE; CYTOKINE PRODUCTION; HINDLIMB; INFLAMMATION; NEUTROPHIL; NONHUMAN; OLIGODENDROGLIA; OSMOTIC PUMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SINGLE DRUG DOSE; SPINAL CORD INJURY; TREATMENT OUTCOME; WHITE MATTER;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; INFLAMMATION; LOWER EXTREMITY; MALE; OLIGODENDROGLIA; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, INTERLEUKIN-8B; SPINAL CORD INJURIES; SULFONAMIDES;

EID: 34548082787     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.107.123679     Document Type: Article

References (41)

1. Baggiolini M, Loetscher P, and Moser B (1995) Interleukin-8 and the chemokine family. Int J Immunopharmacol 17:103-108.
2. Ballermann M and Fouad K (2006) Spontaneous locomotor recovery in spinal cord injured rats is accompanied by anatomical plasticity of reticulospinal fibers. Eur J Neurosci 23:1988-1996.
3. Basso DM, Beattie MS, and Bresnahan JC (1995) A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 12:1-21.
4. Bertini R, Allegretti M, Bizzarri C, Moriconi A, Locati M, Zampella G, Cervellera MN, Di Cioccio V, Cesta MC, Galliera E, et al. (2004) Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: prevention of reperfusion injury. Proc Natl Acad Sci U S A 101:11791-11796.
5. Boyle EM Jr, Canty TG Jr, Morgan EN, Yun W, Pohlman TH, and Verrier ED (1999) Treating myocardial ischemia-reperfusion injury by targeting endothelial cell transcription. Ann Thorac Surg 68:1949-1953.
6. Bracken MB (2002) Methylprednisolone and spinal cord injury. J Neurosurg 96:140-141.
7. Cavalieri B, Mosca M, Ramadori P, Perrelli M, De Simone L, Colotta F, Bestini R, Poli G, and Cutrin JC (2005) Neutrophil recruitment in the reperfused-injured rat liver was effectively attenuated by repertaxin, a novel allosteric noncompetitive inhibitor of CXCL8 receptors: a therapeutic approach for the treatment of post-ischemic hepatic syndromes. Int J Immunopathol Pharmacol 18:475-486.
8. Chertov O, Yang D, Oward OMZ, and Oppenheim JJ (2000) Leukocyte granule proteins mobilized innate host defenses and adaptive immune responses. Immunol Rev 177:68-75.
9. Cugini D, Azzolini N, Gagliardini E, Cassis P, Bertini R, Colotta F, Noris M, Remuzzi G, and Benigni A (2005) Inhibition of cinc-1/interleukin-8 prevents rat kidney graft function deterioration due to ischemia/reperfusion. Kidney Int 67:1753-1761.
10. Diem R, Hobom M, Maier K, Weissert R, Storch MK, Meyer R, and Bahr M (2003) Methylprednisolone increases neuronal apoptosis during autoimmune CNS inflammation by inhibition of an endogenous neuroprotective pathway. J Neurosci 23:6993-7000.
11. Fu ES and Saporta S (2005) Methylprednisolone inhibits production of interleukin-1beta and interleukin-6 in the spinal cord following compression injury in rats. J Neurosurg Anesthesiol 17:82-85.
12. Garau A, Bertini R, Colotta F, Casilli F, Bigini P, Cagnotto A, Mennini T, Ghezzi P, and Villa P (2005) Neuroprotection with the CXCL8 inhibitor repertaxin in transient brain ischemia. Cytokine 30:125-131.
13. Gilmont RR, Dardano A, Engle JS, Adamson BS, Welsh MJ, Li T, Remick DG, Smith DJ Jr, and Rees RS (1996) TNF-alpha potentiates oxidant and reperfusion-induced endothelial cell injury. J Surg Res 61:175-182.
14. Giulian D, Vaca K, and Corpuz M (1993) Brain glia release factors with opposing actions upon neuronal survival. J Neurosci 13:29-37.
15. Gorio A, Gokmen N, Erbayraktar S, Yilmaz O, Madaschi L, Cichetti C, Di Giulio AM, Vardar E, Cerami A, and Brines M (2002) Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma. Proc Natl Acad Sci U S A 99:9450-9455.
16. Gorio A, Madaschi L, Di Stefano B, Carelli S, Di Giulio AM, De Biasi S, Coleman T, Cerami A, and Brines M (2005) Methylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury. Proc Natl Acad Sci U S A 102:16379-16384.
17. Grossman SD, Rosenberg LJ, and Wrathall JR (2001) Temporal-spatial pattern of acute neuronal and glial loss after spinal cord contusion. Exp Neurol 168:273-282.
18. Hayashi M, Ueyama T, Nemoto K, Tamaki T, and Senba E (2000) Sequential mRNA expression for immediate early genes, cytokines, and neurotrophins in spinal cord injury. J Neurotrauma 17:203-218.
19. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals, 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington DC.
20. Kwon BK, Tetzlaff W, Grauer JN, Beiner J, and Vaccaro AR (2004) Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J 4:451-464.
21. Lankhorst AJ, ter Laak MP, Hamers FP, and Gispen WH (2000) Combined treatment with alphaMSH and methylprednisolone fails to improve functional recovery after spinal injury in the rat. Brain Res 859:334-340.
22. Merchant SH, Gurule DM, and Larson RS (2003) Amelioration of ischemia-reperfusion injury with cyclic peptide blockade of ICAM-1. Am J Physiol 284:1260-1268.
23. Merola A, O'Brien MF, Castro BA, Smith DA, Eule JM, Lowe TG, Dwyer AP, Haher TR, and Espat NJ (2002) Histologic characterization of acute spinal cord injury treated with intravenous methylprednisolone. J Orthop Trauma 16:155-161.
24. Merrill JE and Benveniste EN (1996) Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci 19:331-338.
25. Miura M, Fu X, Zhang QW, Remick DG, and Fairchild RL (2001) Neutralization of Gro alpha and macrophage inflammatory protein-2 attenuates renal ischemia/reperfusion injury. Am J Pathol 159:2137-2145.
26. Nakashima S, Matsuyama Y, Yu Y, Kiuchi K, and Ishiguro N (2004) Suppression of GDNF production by MPSS treatment following spinal cord injury in the rat. Neuroreport 15:2337-2340.
27. Park C, Sakamaki K, Tachibana O, Yamashima T, Yamashita J, and Yonehara S (1998) Expression of Fas antigen in the normal mouse brain. Biochem Biophys Res Commun 252:623-628.
28. Raivich G, Bohatschek M, Kloss CU, Werner A, Jones LL, and Kreutzberg GW (1999) Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function. Brain Res Rev 30:77-105.
29. Sapolsky RM and Pulsinelli WA (1985) Glucocorticoids potentiate ischemic injury to neurons: therapeutic implications. Science 229:1397- 1400.
30. Scapini P, Lapinet-Vera JA, Gasperini S, Calzetti F, Buzzoni F, and Cassatella MA (2000) The neutrophil as a source of chemokines. Immunol Rev 177:195-200.
31. Schlayer HJ, Laaff H, Peters T, Woort-Menker M, Estler HC, Karck U, Schaefer HE, and Decker K (1988) Involvement of tumor necrosis factor in endotoxin-triggered neutrophil adherence to sinusoidal endothelial cells of mouse liver and its modulation in acute phase. J Hepatol 7:239-249.
32. Schnell L, Fearn S, Klassen H, Schwab ME, and Perry VH (1999) Acute inflammatory responses to mechanical lesions in CNS: differences between brain and spinal cord. Eur J Neurosci 11:3648-3658.
33. Short DJ, El Masry WS, and Jones PW (2000) High dose methylprednisolone in the management of acute spinal cord injury - a systematic review from a clinical perspective. Spinal Cord 38:273-286.
34. Souza DG, Bertini R, Vieira A, Cunha FQ, Poole S, Allegretti M, Colotta F, and Teixeira MM (2004) Repertaxin, a novel inhibitor of rat CXCR2 function, inhibits inflammatory responses that follow intestinal ischemia and reperfusion injury. Br J Pharmacol 143:132-142.
35. Souza DG, Cassali GD, Poole S, and Teixeira MM (2001) Effects of inhibition of PDE4 and TNF-alpha on local and remote injuries following ischaemia and reperfusion injury. Br J Pharmacol 134:985-994.
36. Souza DG, Soares AC, Pinho V, Torloni H, Reis LF, Teixeira MM, and Dias AA (2002) Increased mortality and inflammation in tumor necrosis factor-stimulate gene-14 transgenic mice after ischemia and reperfusion injury. Am J Pathol 160:1755-1765.
37. Sroga JM, Jones TB, Kigerl KA, McGaughy VM, and Popovich PG (2003) Rats and mice exhibit distinct inflammatory reactions after spinal cord injury. J Comp Neurol 462:223-240.
38. Szabo C (2003). Multiple pathways of peroxynitrite cytotoxicity. Toxicol Lett 140-141:105-112.
39. Vitellaro-Zuccarello L, Mazzetti S, Madaschi L, Bosisio P, Gorio A, and De Biasi S (2007) Erythropoietin-mediated preservation of the white matter in rat spinal cord injury. Neuroscience 144:865-877.
40. Willerson JT (1997) Pharmacologic approaches to reperfusion injury. Adv Pharmacol 39:291-312.
41. Zhang J, Li Y, Cui Y, Chen J, Lu M, Elias SB, and Chopp M (2005) Erythropoietin treatment improves neurological functional recovery in EAE mice. Brain Res 1034:34-39.